The p53-independent activation of transcription of p21WAF1/CIP1/SDI1 after acute renal failure

American Journal of Physiology

Volumn 271, Issue 6 PART 2, 1996, Pages

  Megyesi, Judit ^a,b   Udvarhelyi, Nora ^a   Safirstein, Robert L ^a   Price, Peter M ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P21; PROTEIN P53;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA REPAIR; ENZYME ACTIVITY; GENE ACTIVATION; GENETIC TRANSCRIPTION; KIDNEY INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRANSACTIVATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ANIMALS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; KIDNEY FAILURE, ACUTE; MALE; MICE; MICE, MUTANT STRAINS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TISSUE DISTRIBUTION; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030462640     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajprenal.1996.271.6.f1211     Document Type: Article

References (39)

1. Anderson, R. J., J. A. Gordon, J. Kim, L. M. Peterson, and P. A. Gross. Renal concentration defect following nonoliguric acute renal failure in the rat. Kidney Int. 21: 583-591,1982.
2. Brugarolas, J., C. Chandrasekaran, J. I. Gordon, D. Beach, T. Jacks, and G. J. Hannon. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature Lond. 377: 552-557, 1995.
3. Buerkert, J., M. Head, and S. Klahr. Effects of acute bilateral ureteral obstruction on deep nephron and terminal collecting duct function in the young rat. J. Clin. Invest. 59: 1055-1065, 1977.
4. Caelles, C., A. Helmberg, and M. Karin. p53-Dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature Lond. 370: 220-223,1994.
5. Deng, C., P. Zhang, J. W. Harper. S. J. Elledge, and P. Leder. Mice lacking p21 CIP1/WAF1 undergo normal development, but are defective in Gl checkpoint control. Cell 82: 675-684,1995.
6. Dulic, V., W. K. Kaufmann, S. J. Wilson, T. D. Tlsty, E. Lees, J. W. Harper, S. J. Elledge, and S. I. Reed. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76: 1013-1023, 1994.
7. El-Deiry, W. S., J. W. Harper, P. M. O'Conner, V. E. Velculescu, C. E. Canman, J. Jackman, J. A. Pietenpol, M. Burrell, D. E. Hill, Y. Wang, K. G. Wiman, W. E. Mercer, M. B. Kastan, K. W. Kohn, S. J. Elledge, K. W. Kinzler, and B. Vogelstein. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 54:1169-1174,1994.
8. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. WAF-1, a potential mediator of p53 tumor suppression. Cell 75: 817-825,1993.
9. Flores-Rozas, H., Z. Kelman, F. B. Dean, Z.-Q. Pan, J. W. Harper, S. J. Elledge, M. O'Donnell, and J. Hurwitz. Cdkinteracting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase delta holoenzyme. Proc. Natl. Acad. Sci. USA 91: 8655-8659,1994.
10. Gu, Y., C. W. Turck, and D. O. Morgan. Inhibition of cdk2 activity in vivo by an associated 20K regulatory subunit. Nature Lond. 366: 707-710,1993.
11. Halevy, O., B. G. Novitch, D. B. Spicer, S. X. Skapek, J. Rhee, G. J. Hannon, D. Beach, and A. B. Lassar. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 bymyoD. Science Wash. DC 267:1018-1021,1995.
12. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. The p21 cdk-interacting protein Cipl is a potent inhibitor of Gl cyclin-dependent kinases. Cell 75:805-816,1993.
13. Jiang, H., J. Lin, Z. Z. Su, F. R. Collart, E. Huberman, and P. B. Fisher. Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21, WAF1/CIP1, expression in the absence of p53. Oncogene 9: 3397-3406,1994.
14. Johnson, M., D. Dhnitrov, P. J. Vojta, J. C. Barrett, A. Noda, O. M. Pereira-Smith, and J. R. Smith. Evidence for a p53independent pathway for upregulation of SDI1/CIP1/WAF1/p21 RNA in human cells. Mol. Carcinog. 11: 59-64,1994.
15. Kennedy II, W. A., A. Stenberg, G. Lackgren, T. W. Hensle, and I. S. Sawczuk. Renal tubular apoptosis after partial ureteral obstruction. J. Urol. 152: 658-664, 1994.
16. Kobayashi, T., U. Consoli, M. Andreeff, H. Shiku, A. B. Deisseroth, and W. Zhang. Activation of p21WAF1/Cip1 expression by a temperature-sensitive mutant of human p53 does not lead to apoptosis. Oncogene 11: 2311-2316, 1995.
17. Levine, A. J., J. Moniand, and C. A. Finlay. The p53 tumor suppressor gene. Nature Lond. 351:453-456, 1991.
18. Li, R., S. Waga, G. J. Hannon, D. Beach, and B. Stillman. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature Lond. 371: 534-537, 1994.
19. Li, Y., C. W. Jenkins, M. A. Nichols, and Y. Xiong. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogens 9: 2261-2268,1994.
20. Livingstone, L. R., A. White, J. Sprouse, E. Livanos, T. Jacks, and T. D. Tlsty. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70: 923-935,1992.
21. Macleod, K. F., N. Sherry, G. Hannon, D. Beach, T. Tokino, K. Kinzler, B. Vogelstein, and T. Jacks. p53-Dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev. 9: 935-944,1995.
22. Megyesi, J., J. DiMari, N. Udvarhelyi, P. M. Price, and R. Saflrstein. DNA synthesis is dissociated from the immediateearly gene response in the post-ischemic kidney. Kidney Int. 48: 1451-1458,1995.
23. Michieli, P., M. Chedid, D. Lin, J. H. Pierce, W. E. Mercer, and D. Givol. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 54: 3391-3395,1994.
24. Noda, A. F., Y. Ning, S. Venable, O. M. Pereira-Smith, and J. R. Smith. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211: 90-98, 1994.
25. Parker, S. B., G. Eichele, P. Zhang, A. Rawls, A. T. Sands, A. Bradley, E, N. Olson, J. W. Harper, and S. J. Elledge. p53-Independent expression of p21 Cipl in muscle and other terminally differentiating cells. Science Wash. DC 267: 10241027,1995.
26. Price, P. M., J. Megyesi, S. Saggi, and R. L. Saflrstein. Regulation of transcription by the rat BGF gene promoter in normal and ischémie murine kidney cells. Am. J. Physiol. 268 (Renal Fluid Electrolyte Physiol. 37): F664-F670,1995.
27. Price, P. M., J. Megyesi, N. Udvarhelyi, and R. L. Safirstein. Control of gene activation and repression following acute renal failure by the p53 tumor suppressor protein (Abstract). J. Am. Soc. Nephrol. 5: 906,1994.
28. Saflrstein, R. L., P. Miller, S. Dickman, N. Lyman, and C. Shapiro. Cisplatin nephrotoxicity in rat: defect in papillary hypertonicity.Am. J. Physiol. 241 (Renal Fluid Electrolyte Physiol. 10): F175-F185,1981.
29. Safirstein, R., A. Z. Zelent, and P. M. Price. Reduced levels of prepro epidermal growth factor mRNA and decreased urinary EGF excretion in acute renal failure. Kidney Int. 36: 810-815, 1989.
30. Schumer, M., M. C. Colombel, I. S. Sawczuk, G. Gobe, J. Connor, K. M. O'Toole, C. A. Olsson, G. J. Wise, and R. Buttyan. Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am. J. Pathol. 140:831-838,1992.
31. Sierra, F., J.-M. Tian, and U. Schibier. In vitro transcription with nuclear extracts from differentiated tissues. In: Gene Transcription, edited by B. D. Hames and S. J. Higgins. Oxford, UK: IRL, 1993, p. 125-152.
32. Skapek, S. X., J. Rhee, D. B. Spicer, and A. B. Lassar. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin Dl-dependent kinase. Science Wash. DC 267: 10221024,1995.
33. Storch, S., S. Saggi, J. Megyesi, P. M. Price, and R. Safirstein. Ureteral obstruction decreases renal prepro-epidermal growth factor and Tamm-Horsfall expression. Kidney Int. 42: 89-94,1992.
34. Waga, S., G. J. Hannon, D. Beach, and B. Stillman. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature Lond. 369: 574-578,1994.
35. Wagner, A. J., J. M. Kokontis, and N. Hay. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21 wafl/cipl. Genes Dev. 8: 2817-2830,1994.
36. Wu, H., M. Wade, L. Krall, J. Grisham, Y. Xiong, and T. Van Dyke. Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development, and regeneration. Genes Dev. 10: 245-260,1996.
37. Xiong, Y., G. J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. p21 is a universal inhibitor of cyclin kinases. Nature Land,. 366: 701-704,1993.
38. Xiong, Y., H. Zhang, and D. Beach. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71: 505-514,1992.
39. Zhang, H., G. J. Hannon, and D. Beach. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev. 8: 1750-1758,1994.